Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases

Abroad (travel likely)Recruiting

Conditions

Tetralogy of Fallot · Congenital Heart Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic in Rochester, Rochester, Minnesota, United States
Contact: Study coordinator (Halley Davison) · RSTACHDRESPRG@mayo.edu · 507-422-6246
Contact: Principal Investigator (Alexander Egbe, MBBS, MPH)

Study leads

Alexander Egbe, MBBS, MPH
Principal Investigator
Mayo Clinic

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development

Congenital Heart Disease · Tetralogy of Fallot

Abroad (travel likely)Recruiting

Atlanta, United States

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

Adult Congenital Heart Disease · Congenital Heart Disease · Systemic Right Ventricle

Abroad (travel likely)Recruiting

Baltimore, United States · Grand Rapids, United States

High Intensity Interval Training in Patients With a Right Ventricle to Pulmonary Artery Conduit

Congenital Heart Disease · Truncus Arteriosus · Pulmonary Atresia

Abroad (travel likely)Recruiting

Nijmegen, Netherlands · Rotterdam, Netherlands

Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial

Congenital Heart Disease · Repaired Tetralogy of Fallot (rTOF) · Pulmonary Regurgitation

Abroad (travel likely)RecruitingPHASE4

Hong Kong, Hong Kong